AKT1 and Alzheimer disease: According to the network pharmacology analysis, we mainly focused on the anti-inflammatory mechanism of QZZD in treating AD and assembled it into a synthetic pathway (Figure 7), with the TNF signaling pathway as the main pathway, including the Aβ-associated signaling pathway, NF-kappaB signaling pathway and PI3K-Akt signaling pathway.